Soros Fund Management LLC Invests $3,461,000 in CME Group Inc (CME)

Soros Fund Management LLC purchased a new stake in shares of CME Group Inc (NASDAQ:CME) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,000 shares of the company’s stock, valued at approximately $3,461,000.

Several other large investors have also recently made changes to their positions in CME. Princeton Alpha Management LP boosted its stake in shares of CME Group by 1,186.6% in the second quarter. Princeton Alpha Management LP now owns 49,766 shares of the company’s stock valued at $4,847,000 after buying an additional 45,898 shares during the last quarter. Assetmark Inc. boosted its stake in shares of CME Group by 11.6% in the second quarter. Assetmark Inc. now owns 80,914 shares of the company’s stock valued at $7,881,000 after buying an additional 8,387 shares during the last quarter. Ropes Wealth Advisors LLC boosted its stake in shares of CME Group by 16.8% in the second quarter. Ropes Wealth Advisors LLC now owns 7,924 shares of the company’s stock valued at $772,000 after buying an additional 1,142 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of CME Group by 2.9% in the second quarter. Ameriprise Financial Inc. now owns 3,909,381 shares of the company’s stock valued at $380,676,000 after buying an additional 111,901 shares during the last quarter. Finally, FineMark National Bank & Trust boosted its stake in shares of CME Group by 4.3% in the second quarter. FineMark National Bank & Trust now owns 78,946 shares of the company’s stock valued at $7,689,000 after buying an additional 3,232 shares during the last quarter. 80.06% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

CME Group Inc (NASDAQ:CME) traded down 1.8597% during midday trading on Thursday, reaching $124.6382. The company had a trading volume of 1,007,296 shares. CME Group Inc has a 52-week low of $89.00 and a 52-week high of $127.60. The company’s 50-day moving average is $119.86 and its 200 day moving average is $112.53. The company has a market cap of $42.14 billion, a PE ratio of 27.5140 and a beta of 0.88.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, February 2nd. The company reported $1.14 EPS for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.03. The company had revenue of $913 million for the quarter, compared to analyst estimates of $881.46 million. CME Group had a return on equity of 7.28% and a net margin of 42.67%. CME Group’s revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.92 earnings per share. On average, equities research analysts forecast that CME Group Inc will post $4.82 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 27th. Stockholders of record on Friday, March 10th will be given a dividend of $0.66 per share. The ex-dividend date is Wednesday, March 8th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.08%. This is a positive change from CME Group’s previous quarterly dividend of $0.60. CME Group’s dividend payout ratio (DPR) is currently 52.98%.

“Soros Fund Management LLC Invests $3,461,000 in CME Group Inc (CME)” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The original version of this report can be accessed at https://sportsperspectives.com/2017/03/02/soros-fund-management-llc-invests-3461000-in-cme-group-inc-cme.html.

Several equities research analysts recently commented on CME shares. J P Morgan Chase & Co cut CME Group from an “overweight” rating to a “neutral” rating and set a $116.00 price target for the company. in a research note on Monday, November 14th. They noted that the move was a valuation call. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $131.00 price target for the company in a research note on Tuesday, January 10th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $103.96.

In related news, CEO Terrence A. Duffy sold 27,550 shares of the stock in a transaction dated Thursday, December 8th. The stock was sold at an average price of $120.44, for a total transaction of $3,318,122.00. Following the completion of the transaction, the chief executive officer now directly owns 137,914 shares in the company, valued at $16,610,362.16. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Julie Winkler sold 5,888 shares of the stock in a transaction dated Friday, February 24th. The stock was sold at an average price of $122.53, for a total value of $721,456.64. Following the transaction, the insider now owns 14,095 shares of the company’s stock, valued at $1,727,060.35. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 70,532 shares of company stock worth $8,428,445. 0.61% of the stock is currently owned by insiders.

About CME Group

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply